{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:08:16Z","timestamp":1761498496470,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","award":["CA077598","CA111412"],"award-info":[{"award-number":["CA077598","CA111412"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Haematology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.beha.2018.09.012","type":"journal-article","created":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T06:11:00Z","timestamp":1537510260000},"page":"410-413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Can haploidentical transplantation meet all patients' needs?"],"prefix":"10.1016","volume":"31","author":[{"given":"Daniel","family":"Weisdorf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"author":"D'Souza","key":"10.1016\/j.beha.2018.09.012_bib1"},{"issue":"9","key":"10.1016\/j.beha.2018.09.012_bib2","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.bbmt.2016.05.015","article-title":"Changing trends of unrelated umbilical cord blood transplantation for hematologic diseases in patients older than fifty years: a eurocord-center for international blood and marrow transplant Research survey","volume":"22","author":"Rafii","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.beha.2018.09.012_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/s41409-018-0153-1","article-title":"European society for blood and marrow transplantation (EBMT). Is the use of unrelated donor transplantation leveling off in europe? The 2016 european society for blood and marrow transplant activity survey report","author":"Passweg","year":"2018","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.beha.2018.09.012_bib5","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/bmt.2017.22","article-title":"Ex vivo T-cell depletion in allogeneic hematopoietic stem cell transplant: past, present and future","volume":"52","author":"Saad","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"31","key":"10.1016\/j.beha.2018.09.012_bib6","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1200\/JCO.2007.11.6053","volume":"25","author":"Schmid","year":"2007","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.beha.2018.09.012_bib7","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.bbmt.2013.11.020","article-title":"HLA-haploidentical donor lymphocyte infusions for patients with relapsed hematologic malignancies after related HLA-haploidentical bone marrow transplantation","volume":"20","author":"Zeidan","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.beha.2018.09.012_bib8","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","article-title":"HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide","volume":"14","author":"Luznik","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"28","key":"10.1016\/j.beha.2018.09.012_bib9","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1200\/JCO.2014.60.4777","article-title":"Outcomes of nonmyeloablative HLA-haploidentical blood or marrow transplantation with high-dose post-transplantation cyclophosphamide in older adults","volume":"33","author":"Kasamon","year":"2015","journal-title":"J Clin Oncol"},{"issue":"25","key":"10.1016\/j.beha.2018.09.012_bib10","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1182\/blood-2015-02-627786","article-title":"Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study","volume":"125","author":"Wang","year":"2015","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.beha.2018.09.012_bib11","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1182\/blood-2015-04-639831","article-title":"Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia","volume":"26","author":"Ciurea","year":"2015","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.beha.2018.09.012_bib12","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.bbmt.2014.05.015","article-title":"Mismatched related and unrelated donors for allogeneic hematopoietic cell transplantation for adults with hematologic malignancies","volume":"20","author":"Eapen","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"10.1016\/j.beha.2018.09.012_bib13","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1182\/bloodadvances.2018018291","volume":"2","author":"Robinson","year":"2018","journal-title":"Blood Adv"},{"issue":"26","key":"10.1016\/j.beha.2018.09.012_bib14","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1200\/JCO.2017.72.8428","article-title":"Mobilized peripheral blood stem cells versus unstimulated bone marrow as a graft source for T-cell-replete haploidentical donor transplantation using post-transplant cyclophosphamide","volume":"10","author":"Bashey","year":"2017","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.beha.2018.09.012_bib15","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1182\/blood-2011-03-344853","volume":"118","author":"Brunstein","year":"2011","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.beha.2018.09.012_bib16","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1200\/JCO.2014.57.2446","article-title":"Bone marrow or peripheral blood for reduced-intensity conditioning unrelated donor transplantation","volume":"1","author":"Eapen","year":"2015","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.beha.2018.09.012_bib17","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1038\/bmt.2016.215","article-title":"Comparable outcomes with marrow or peripheral blood as stem cell sources for hematopoietic cell transplantation from haploidentical donors after non-ablative conditioning: a matched-pair analysis","volume":"51","author":"O'Donnell","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.beha.2018.09.012_bib18","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1182\/bloodadvances.2017014829","article-title":"Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamide","volume":"2","author":"McCurdy","year":"2018","journal-title":"Blood Adv"},{"issue":"3\u20134","key":"10.1016\/j.beha.2018.09.012_bib19","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.beha.2014.10.010","article-title":"Unrelated donor transplantation: peripheral blood or bone marrow--does it matter?","volume":"27","author":"Eapen","year":"2014","journal-title":"Best Pract Res Clin Haematol"},{"issue":"1","key":"10.1016\/j.beha.2018.09.012_bib20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbmt.2014.09.006","article-title":"Long-term survival after transplantation of unrelated donor peripheral blood or bone marrow hematopoietic cells for hematologic malignancy","volume":"21","author":"Eapen","year":"2015","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Best Practice & Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692618300859?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692618300859?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:04:55Z","timestamp":1761498295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692618300859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S1521692618300859"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2018.09.012","relation":{},"ISSN":["1521-6926"],"issn-type":[{"type":"print","value":"1521-6926"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can haploidentical transplantation meet all patients' needs?","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Haematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beha.2018.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}